Skip to main content
رجوع
SIBN logo

SI-BONE, Inc.

جودة البيانات: 100%
ذروة بيع
SIBN
NASDAQ Healthcare Medical - Devices
KWD 12.99
▲ KWD 0.20 (1.56%)
القيمة السوقية: 573.71M
نطاق اليوم
KWD 12.91 KWD 13.44
نطاق 52 أسبوعًا
KWD 12.50 KWD 21.89
حجم التداول
595,493
متوسط 50 يوم / 200 يوم
KWD 15.68 / KWD 16.73
الإغلاق السابق
KWD 12.79

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -30.3 0.4
P/B 3.2 2.9
ROE % -11.0 3.8
Net Margin % -9.4 3.9
Rev Growth 5Y % 22.2 10.0
D/E 0.0 0.2

السعر المستهدف للمحللين

Hold
KWD 25.250 +94.4%
Low: KWD 23.000 High: KWD 27.000
ربحية السهم المستقبلية
-KWD 0.517
الإيرادات المقدّرة
230 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 0.320
KWD 0.317 – KWD 0.323
400 M 1
FY2029 KWD 0.050
KWD 0.050 – KWD 0.051
350 M 1
FY2028 -KWD 0.260
-KWD 0.270 – -KWD 0.250
310 M 2

النقاط الرئيسية

Revenue grew 22.18% annually over 5 years — strong growth
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -9.09M
Capital efficient — spends only 4.19% of revenue on capex

النمو

Revenue Growth (5Y)
22.18%
Revenue (1Y)20.19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-10.98%
ROIC-9.37%
Net Margin-9.41%
Op. Margin-11.11%

الأمان

Debt / Equity
0.01
Current Ratio8.55
Interest Coverage-4.23

التقييم

P/E Ratio
-30.34
P/B Ratio3.23
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 20.19% Revenue Growth (3Y) 20.28%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 22.18% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 200.93M Net Income (TTM) -18.91M
ROE -10.98% ROA -7.93%
Gross Margin 79.57% Operating Margin -11.11%
Net Margin -9.41% Free Cash Flow (TTM) -9.09M
ROIC -9.37% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.01 Current Ratio 8.55
Interest Coverage -4.23 Dividend Yield 0.00%
Valuation
P/E Ratio -30.34 P/B Ratio 3.23
P/S Ratio 2.86 PEG Ratio 1.10
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 573.71M Enterprise Value 532.59M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 200.93M 167.18M 138.89M 106.41M 90.15M
Net Income -18.91M -30.91M -43.34M -61.26M -56.57M
EPS (Diluted) -0.44 -0.75 -1.13 -1.79 -1.71
Gross Profit 159.88M 132.12M 109.42M 90.70M 79.72M
Operating Income -22.33M -35.25M -46.93M -59.61M -51.67M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 238.56M 230.44M 230.43M 157.55M 190.51M
Total Liabilities 61.02M 63.47M 61.05M 59.25M 56.09M
Shareholders' Equity 177.53M 166.96M 169.38M 98.30M 134.42M
Total Debt 1.12M 37.48M 38.99M 39.43M 40.48M
Cash & Equivalents 42.24M 34.95M 33.27M 20.72M 63.42M
Current Assets 216.12M 207.78M 211.39M 137.61M 175.87M
Current Liabilities 25.28M 27.13M 23.46M 21.18M 16.89M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Full Throttle
#98 of 146
35

النشاط الأخير

دخل Full Throttle
Mar 24, 2026